Globus Enters Tumor and Trauma Segment

August 26, 2005 – PHOENIXVILLE, PA, USA PRNewswire – Globus Medical, Inc., one of the ten largest spinal implant manufacturers in the US, announced today the release of the XPand(TM) Expandable Corpectomy Spacer and the Protex-CT™ Posterior Cervico-Thoracic Fixation System. These products mark the Company’s initial foray into the Tumor and Trauma segments of the spine market and maintain the two-year-old Company’s torrid pace of product introductions.

The XPand™ Expandable Corpectomy Spacer’s unique design allows a surgeon to easily size the device to an infinite variety of anatomical situations. The Protex-CT™ Posterior Cervico-Thoracic Fixation System employs self-tapping, polyaxial screws that allow for an unprecedented 40 degrees of angulation in all directions.

Dr. Alex Vaccaro, MD, Professor of Neurosurgery and Orthopaedic Surgery, Thomas Jefferson University Hospital and Orthopaedic Surgeon and co-Director of the Reconstructive Spine Service at Jefferson’s Rothman Institute commented, “The XPand™ Expandable Corpectomy Spacer marks a breakthrough in vertebral body reconstruction for treating fractures and tumors. The device has a simple, unique expansion and insertion mechanism which gives the surgeon unlimited flexibility.”

Dr. Steven Ludwig, MD, Associate Professor of Orthopaedics and Co-Director, University of Maryland Spine Center commented, “The Protex-CT™ System is an elegant, comprehensive system for occipito-cervico-thoracic fixation for tumor, trauma, and degenerative conditions. The design of the Protex-CT™ screw with 40 degree angulation in all planes simplifies the procedure and allows for greater flexibility in screw placement.”

Rick Kienzle, Executive Vice President of Sales and Marketing for Globus commented, “The launch of these two products further validates the unique product development approach pioneered by Globus. In just 30 months from inception, we have introduced a full line of fusion products to treat degenerative spine conditions, a spine arthroplastic device currently in clinical trials and now these products to treat patients with spine tumor and trauma conditions. We are building momentum that promises to produce explosive growth in 2006 as we expand our distribution base across the US.”

Globus was founded in 2003 by a team of spine professionals, with a vision to create products that enable spine surgeons to employ both fusion and non- fusion solutions to promote healing in patients with spinal disorders. Today Globus is one of the fastest growing companies in the spinal device industry and is a recognized leader in the development of motion sparing technology. Since its inception, Globus has vaulted into the top 10 spine technology companies in the U.S., with over $40 million in annualized revenues. Globus’ success is a result of its extensive surgeon collaboration in product development, its innovative cutting edge technology and its unprecedented record for speed in product development from the design phase through FDA approval to market introduction. Today, Globus has a full portfolio of products to meet all of a spine surgeon’s needs and is one of the world’s leaders in the development of motion sparing technology.